Financial News from Mad Money from 11/3/2009

Sealy Corporation (ZZ) Discussed on CNBC's Mad Money

Sealy Corporation is in the news. Find out how this impacts ZZ trading on Ockham Research.

Ask me.Even if you think yourmattress is just fine... Ask me what it's like toget your best night's sleep every night. Why not talk to someonewho's sleeping on the most highly recommendedbed in america... It's not a SEALY... Or a serta... Ask me about mytempur-pedic. Ask me how fasti fall asleep. Ask me aboutstaying asleep. These are actualtempur-pedic owners! Ask someone youknow---check out twitter... Try your fiends on facebook. You'll hear itall...Un-edited. Ask me how it feelsafter 10 years. Ask me if it'sa good value. Just ask me. There are over 4 milliontempur-pedic owners!

“… empur-pedic. Ask me how fasti fall asleep. Ask me aboutstaying asleep. These are actualtempur-pedic owners! Ask someone youknow---check out twitter... Try your fiends on facebook. You'll hear itall...Un-edited. Ask me how it feelsafter 10 years. Ask me if it'sa good value. Just ask me. There are over 4 milliontempur-pedic owners! …”

The Hartford Financial Services Group, Incorporated (HIG) Discussed on CNBC's Mad Money

The Hartford Financial Services Group, Incorporated is in the news. Find out how this impacts HIG trading on Ockham Research.

>>> after of close, HARTFORD FINANCIAL came out and reported a blowout number. More important, they boosted forecast to where you saw the book value, that's got a $36 book that's going higher. I like to say there's always a bull market somewhere. I prooms to try to find it for i'm jim cramer. I will see you tomorrow.

“… to try to find it for i'm jim cramer. I will see you tomorrow. …”

Apple, Incorporated (AAPL) Discussed on CNBC's Mad Money

Apple, Incorporated is in the news. Find out how this impacts AAPL trading on Ockham Research.

I have been buying chu for my travel trust and sent out a similar e-mail saying people are really, really making a mole hill out of a mountain here. I think APPLE sales are going to be gigantic in china. I continue to like both chu and APPLE. Bill in irvine weighs in. Dear cramer, since the beginning of august, I noticed the dow jones average has switched from seeing support at the 20-day moving average to support at 509-day moving average. Is this a bearish sign for the why does a price of the stock even care if it touches these

“… ne weighs in. Dear cramer, since the beginning of august, I noticed the dow jones average has switched from seeing support at the 20-day moving average to support at 509-day moving average. Is this a bearish sign for the why does a price of the stock even care if it touches these …”

TheStreet.com, Incorporated (TSCM) Discussed on CNBC's Mad Money

TheStreet.com, Incorporated is in the news. Find out how this impacts TSCM trading on Ockham Research.

Now we're talking about the tsunami that's had the big pullback -- by the way, my friend brian ashtonburg. Breakout stocks for THESTREET.COM where i'm we believe david auldridge is going to have a good quarter and this stock should be bought. The group is for sale. I say you buy buy buy, not sell sell sell. And I say you stick with cramer!

“… for sale. I say you buy buy buy, not sell sell sell. And I say you stick with cramer! …”

Synaptics Incorporated (SYNA) Discussed on CNBC's Mad Money

Synaptics Incorporated is in the news. Find out how this impacts SYNA trading on Ockham Research.

Recoil from snapanti-ic SYNAPTICS? >> no, let's buy some cypress. David in michigan. >> caller: michigan ba-ba-ba-boo-yah. >> i'm liking that whole motor state boo-yah at you. Zwref daniels jeff daniels boo-yah. >> we've got cypress, skyworks.

“… Recoil from snapanti-ic SYNAPTICS? >> no, let's buy some cypress. David in michigan. >> caller: michigan ba-ba-ba-boo-yah. >> i'm liking that whole motor state boo-yah at you. Zwref daniels jeff daniels boo-yah. >> we've got cypress, skyworks. …”

Illini Corporation (ILII) Discussed on CNBC's Mad Money

Illini Corporation is in the news. Find out how this impacts ILII trading on Ockham Research.

Limited. >> I think epd is right to buy I will always take an 8% yield I believe is safe. Now we want to go to diane in the ILLINI. Diane. >> caller: wishing you a way to go chase utley boo-yah. >> i'm going to tell you that I think i'm seeing reggie jackson in the making but unfortunately i'm also seeing ryan howard going to get the striekt record. How do I help? >> caller: my stock is agnc. American capital agency. It's got a huge dividend and a great yield.

“… son in the making but unfortunately i'm also seeing ryan howard going to get the striekt record. How do I help? >> caller: my stock is agnc. American capital agency. It's got a huge dividend and a great yield. …”

Windstream Corporation (WIN) Discussed on CNBC's Mad Money

Windstream Corporation is in the news. Find out how this impacts WIN trading on Ockham Research.

Deceptive dividend, these guys are paying out twice what they're taking I >> and jim, that's why you're going to sell the stock I think it's dangerous. If you want to have a high-yielding telco i'll send you to WINDSTREAM which dp a pretty good acquisition today. You're playing the wrong table at the mohegan sun, my friend. How about we go to scott in texas? Scott. >> caller: boo-yah, jim. >> yeah, this way. Poke 'em horns. >> caller: I just got your book. It's very, very good reading. I'm only into the third chapter --

“… n today. You're playing the wrong table at the mohegan sun, my friend. How about we go to scott in texas? Scott. >> caller: boo-yah, jim. >> yeah, this way. Poke 'em horns. >> caller: I just got your book. It's very, very good reading. I'm only into the third chapter -- …”

Celgene Corporation (CELG) Discussed on CNBC's Mad Money

Celgene Corporation is in the news. Find out how this impacts CELG trading on Ockham Research.

Ceo wants to come on and tell us the dividend's safe a la wind stream, welcome. But i'm not sticking my neck out i've had it chopped off too I like CELGENE, but i'm obeying the chartists and saying don't buy it until it gets to the 48 level. Its cancer franchise, though, is par excellence. Let's wait before we pull the stay with cramer. >> announcer: next, try to keep one cramer as he takes your calls rapid-fire in an all new "lightning round."

“… anchise, though, is par excellence. Let's wait before we pull the stay with cramer. >> announcer: next, try to keep one cramer as he takes your calls rapid-fire in an all new "lightning round." …”

PDL Biopharma, Incorporated (PDLI) Discussed on CNBC's Mad Money

PDL Biopharma, Incorporated is in the news. Find out how this impacts PDLI trading on Ockham Research.

>> oh, new -- hey, fantastic. Tappan zee boo-yah. >> caller: yes, sir. Hey, jim, my question's about PDL BIOPHARMA. Love the dividend they pay, but I don't know how to value them. Their only asset are the palpitateents for these phenomenal cancer drugs, but the patents expire in 2013, 2014. >> I don't want to touch this this one i've been around the block on. There's been arbitragers trying to break it up. There's been hedge funds trying to make value here. And they can't seem to be

“… ut the patents expire in 2013, 2014. >> I don't want to touch this this one i've been around the block on. There's been arbitragers trying to break it up. There's been hedge funds trying to make value here. And they can't seem to be …”

Emergent BioSolutions, Incorporated (EBS) Discussed on CNBC's Mad Money

Emergent BioSolutions, Incorporated is in the news. Find out how this impacts EBS trading on Ockham Research.

I'm a crimsonoid myself. Hit me, mook. Is that like mel k? Isn't melk injured? Okay, mook, you're filling in for melk. >> caller: there you go. I'm calling about EMERGENT BIOSOLUTIONS. This company seems to fit into the homeland security theme. It's a pharma company that focuses on the biodefense segment with its two biggest customers being the department of defense and health and human >> caller: but it appears pretty I think the company has a pretty good balance sheet and just yesterday it was added to the

“… rma company that focuses on the biodefense segment with its two biggest customers being the department of defense and health and human >> caller: but it appears pretty I think the company has a pretty good balance sheet and just yesterday it was added to the …”